index: hide
name: Neoplasm-Related Conditions


The table below lists some of the codes that listed in the ICD-10-CM index for conditions that are present in a patient who also has a malignancy. When medical coders use these codes, they are also instructed to code the underlying neoplasm if known.

<table class="table table-striped">
	<tbody><tr>
		<th width="20%" scope="col">ICD-10-CM Code</th>
		<th scope="col">ICD-10-CM Description</th>
	</tr>
	<tr>
		<td>D61.82</td>
		<td>Myelophthisis</td>
	</tr>
	<tr>
		<td>D63.0</td>
		<td>Anemia  in neoplastic disease (C00-D49)</td>
	</tr>
	<tr>
		<td>D64.81</td>
		<td>Anemia due to  antineoplastic chemotherapy</td>
	</tr>
	<tr>
	  <td>D72.1</td>
	  <td>Eosinophilia</td>
    </tr>
	<tr>
	  <td>D75.8</td>
	  <td>Myelofibrosis </td>
    </tr>
	<tr>
	  <td>E08</td>
	  <td>Diabetes  mellitus due to underlying condition (C00-C96) </td>
    </tr>
	<tr>
	  <td>E31.2-</td>
	  <td>Multiple  endocrine neoplasia [MEN] syndromes</td>
    </tr>
	<tr>
	  <td>E34.0</td>
	  <td>Carcinoid  syndrome (maybe used as additional code to identify functional activity of a  carcinoid tumor)</td>
    </tr>
	<tr>
	  <td>E88.3</td>
	  <td>Tumor  lysis syndrome (following antineoplastic chemotherapy)</td>
    </tr>
	<tr>
	  <td>G13.0</td>
	  <td>Paraneoplastic  neuromyopathy and neuropathy (C00-D49)</td>
    </tr>
	<tr>
	  <td>G13.1</td>
	  <td>Other  systemic atrophy primarily affecting central nervous system in neoplastic  disease (C00-D49)</td>
    </tr>
	<tr>
	  <td>G32.8-</td>
	  <td>Other  specified degenerative disorders of nervous system in diseases classified  elsewhere</td>
    </tr>
	<tr>
	  <td>G53</td>
	  <td>Cranial  nerve disorders in disease classified elsewhere (C00-D49)</td>
    </tr>
	<tr>
	  <td>G55</td>
	  <td>Nerve  root and plexus compression in diseases classified elsewhere (C00-D49)</td>
    </tr>
	<tr>
	  <td>G63</td>
	  <td>Polyneuropathy  in disease classified elsewhere (C00-D49)</td>
    </tr>
	<tr>
	  <td>G73.1</td>
	  <td>Lambert-Eaton  syndrome in neoplastic disease (C00-D49)</td>
    </tr>
	<tr>
	  <td>G89.3</td>
	  <td>Neoplasm  related pain</td>
    </tr>
	<tr>
	  <td>G99.2</td>
	  <td>Myelopathy  in diseases classified elsewhere (C00-D49)</td>
    </tr>
	<tr>
	  <td>H47.42</td>
	  <td>Disorders  of optic chiasm in (due to) neoplasm</td>
    </tr>
	<tr>
	  <td>H47.52-</td>
	  <td>Disorders  of visual pathways in (due to) neoplasms</td>
    </tr>
	<tr>
	  <td>H47.63-</td>
	  <td>Disorders  of visual cortex in (due to) neoplasm </td>
    </tr>
	<tr>
	  <td>J91.0</td>
	  <td>Malignant  pleural effusion (Code neoplasm first)</td>
    </tr>
	<tr>
	  <td>J93.12</td>
	  <td>Secondary  pneumothorax (Code first neoplasm of lung)</td>
    </tr>
	<tr>
	  <td>M36.0</td>
	  <td>Dermato(poly)  myositis in neoplastic disease (C00-D49)</td>
    </tr>
	<tr>
	  <td>M36.1</td>
	  <td>Arthropathy  in neoplastic disease (C00-D49)</td>
    </tr>
	<tr>
	  <td>M84.5-</td>
	  <td>Pathologic  fracture in neoplastic disease (Code also underlying neoplasm)</td>
    </tr>
	<tr>
	  <td>M90.6-</td>
	  <td>Osteitis  deformans in neoplastic disease (Code neoplasm first C40.-,C41.-)</td>
    </tr>
	<tr>
	  <td>O9A.1-</td>
	  <td>Malignant  neoplasm complicating pregnancy, childbirth and the puerperium) C00-C96)</td>
    </tr>
	<tr>
	  <td>R18.0</td>
	  <td>Malignant  ascites (Code neoplasm first)</td>
    </tr>
	<tr>
	  <td>R53.0</td>
	  <td>Neoplasm  (malignant) related fatigue (Code neoplasm first)</td>
    </tr>
  </tbody></table>
